|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-29S1
|
$86,403
|
$5,184
|
NICHOLS, CRAIG
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Utilizing HuR to optimize the treatment of pancreatic cancer
|
1R21CA182692-01A1
|
$202,275
|
$101,138
|
BRODY, JONATHAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-28S1
|
$48,718
|
$2,436
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-28
|
$1,485,000
|
$74,250
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-29S1
|
$365,619
|
$179,153
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S1
|
$74,531
|
$1,491
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S2
|
$49,999
|
$1,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S3
|
$310,728
|
$6,215
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-26
|
$5,914,688
|
$118,294
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-07S1
|
$355,196
|
$7,104
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-07
|
$1,535,000
|
$30,700
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
Understanding resistance in the HER2-HER3 tumor drive
|
5R01CA122216-07
|
$288,760
|
$72,190
|
MOASSER, MARK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Tumor-targeted Polymersomes to image and Treat Ovarian Cancer
|
5R01CA175480-02
|
$318,010
|
$159,005
|
CHENG, ZHILIANG
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Tumor Tight Junction Opener + Chemotherapy Conjugates to Treat Cancer
|
1R43CA183379-01
|
$191,159
|
$95,580
|
CARTER, DARRICK
|
PAI LIFE SCIENCES, INC.
|
|
|
Translational Research in Cancer
|
3P30CA056036-15S1
|
$73,216
|
$732
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Translational Research in Cancer
|
5P30CA056036-15
|
$2,723,515
|
$27,235
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Transgenic Models for Prostate and Breast Cancer
|
ZIA BC 005740
|
$665,463
|
$13,309
|
Green, Jeffrey
|
CCR (NCI)
|
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
2R01CA070375-18A1
|
$268,515
|
$134,258
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY
|
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
3U10CA035415-30S1
|
$346,487
|
$20,789
|
MOWAT, REX
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
3R01CA115483-10S1
|
$51,944
|
$25,972
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
5R01CA115483-10
|
$281,879
|
$140,940
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
Theranostic nanoparticles for the treatment of RAI refractory thyroid cancer
|
5R01CA178007-02
|
$341,162
|
$170,581
|
JIN, MOONSOO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA083639-15
|
$2,093,826
|
$125,630
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
The Role of SRC-1 in Breast Cancer
|
5R01CA112403-08
|
$261,640
|
$65,410
|
XU, JIANMING
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The pathophysiology and palliation of the paclitaxel-induced acute pain syndrome
|
1R21CA180997-01
|
$192,765
|
$192,765
|
JATOI, AMINAH
|
MAYO CLINIC ROCHESTER
|
|
|
The NFkB-dependent Secretome and Invasion/Angiogenesis in Thyroid Cancer
|
5R01CA155512-04
|
$300,185
|
$150,093
|
HAUGEN, BRYAN
|
UNIVERSITY OF COLORADO DENVER
|
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S5
|
$110,177
|
$12,119
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
|
|
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
|
ZIA SC 010098
|
$545,007
|
$27,250
|
Dahut, William
|
CCR (NCI)
|
|
|
The critical role of GRP78 for endometrial cancer development and progression
|
1K08CA175161-01A1
|
$175,824
|
$58,022
|
LIN-LIU, YVONNE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
The Bcl-2-p85/PI3K signaling axis
|
5R01CA140980-05
|
$380,712
|
$190,356
|
ZHANG, XIAO-KUN
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
|
Taxol: Mechanisms of Action and Resistance
|
5R01CA077263-14
|
$390,474
|
$390,474
|
HORWITZ, SUSAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Targeting Stromal Collagen in Pancreatic Cancer
|
5R01CA169281-02
|
$375,126
|
$187,563
|
HAN, HAIYONG
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
|
|
TARGETING SPLEEN TYROSINE KINASE IN CHEMORESISTANT OVARIAN CARCINOMA
|
1R21CA187512-01
|
$211,410
|
$211,410
|
WANG, TIAN-LI
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Targeting microtubule stabilization to reduce breast tumor metastasis
|
5R01CA154624-03
|
$308,957
|
$154,479
|
MARTIN, STUART
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
TARGETED INTERVENTION OF BREAST ONCOGENIC PATHWAYS
|
5R01CA098473-10
|
$301,721
|
$75,430
|
SEBTI, SAID
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Targeted Combination Therapy for Breast Cancer
|
1R01CA174305-01A1
|
$312,128
|
$312,128
|
LI, SONG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Taccalonolides: Mechanisms of Action and Cellular Resistance
|
5R01CA121138-09
|
$249,938
|
$62,485
|
MOOBERRY, SUSAN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
|
Synthesis, Biosynthesis, and Structure of Antitumor Agents
|
5R01CA076497-15
|
$279,329
|
$69,832
|
HOYE, THOMAS
|
UNIVERSITY OF MINNESOTA
|
|
|
Synergistic chemo-siRNA combination therapy
|
5R01CA158300-04
|
$361,309
|
$361,309
|
WIENTJES, M
|
OPTIMUM THERAPEUTICS, LLC
|
|
|
SWOG Community Clinical Oncology Program Research Base
|
3U10CA037429-29S2
|
$579,978
|
$34,799
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
SunCoast CCOP Research Base at the University of South Florida
|
3U10CA081920-12S1
|
$304,356
|
$6,087
|
KRISCHER, JEFFREY
|
UNIVERSITY OF SOUTH FLORIDA
|
|
|
SunCoast CCOP Research Base at the University of South Florida
|
3U10CA081920-12S2
|
$990,693
|
$19,814
|
KRISCHER, JEFFREY
|
UNIVERSITY OF SOUTH FLORIDA
|
|
|
Stromal depletion for pancreatic cancer therapy
|
5R21CA176339-02
|
$121,674
|
$121,674
|
LI, SHYH-DAR
|
ONTARIO INSTITUTE FOR CANCER RESEARCH
|
|
|
Stromal depletion for pancreatic cancer therapy
|
7R21CA176339-03
|
$123,139
|
$123,139
|
LI, SHYH-DAR
|
UNIVERSITY OF BRITISH COLUMBIA
|
|
|
Stanford University Cancer Center
|
3P30CA124435-08S1
|
$75,000
|
$750
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
Stanford University Cancer Center
|
3P30CA124435-08S2
|
$323,044
|
$3,230
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
Stanford University Cancer Center
|
5P30CA124435-08
|
$2,998,871
|
$29,989
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
3U10CA095968-12S1
|
$139,195
|
$2,784
|
JASLOWSKI, ANTHONY
|
ST. VINCENT HOSPITAL
|
|
|
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
|
5P50CA168504-02
|
$2,162,001
|
$64,860
|
WINER, ERIC
|
DANA-FARBER CANCER INST
|
|
|
SPORE in Breast Cancer
|
5P50CA098131-12
|
$2,161,998
|
$540,500
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
Total relevant funding to Taxol for this search: $18,673,073
|
